By Hilary White
TORONTO, December 8, 2005 (LifeSiteNews.com) – The Ontario College of Pharmacists has declared that the Morning After Pill (MAP), the abortifacient drug known to carry serious health risks to women, will hereafter be dispensed without a complete medical history being taken by the pharmacist.
Last week, Ontario’s privacy commissioner Ann Cavoukian, complained that screening women for their sexual history before dispensing the drug was a violation of their privacy. This despite the well-documented health risks of the drug which is a massive dose of the same kinds of hormones found in regular birth control pills.
Voluntary guidelines issued by the Canadian Pharmacists Association only recommended that pharmacists collect the information, some of which Cavoukian said was “extremely sensitive,” before dispensing the drug, called “Plan B.”
A media release from Cavoukian’s office said that the privacy issue could become “a potential barrier to accessing emergency contraception.”
That the drug ought to be dispensed without any “barriers,” however, is an article of faith to the feminist-driven medical community, even to the point of risking the health or potentially, the lives of women exposed to it.
Even promoters of the drug admit that women with preexisting medical conditions, including established pregnancy, past heart attack or stroke, blood clots in the legs or lungs, breast or genital cancers, are at serious risk with the drug. Additional warnings are included for those women who plan to have intercourse within 5 days, are breastfeeding or have given birth in the last 6 weeks, have epilepsy, cardiovascular or kidney disease, migraine headaches, diabetes, or hypertension.
Despite these serious medical considerations, MAP is now available throughout Canada without a doctor’s prescription or supervision. Representatives of the Ontario College of Pharmacists, the Ontario Pharmacists Association and the Canadian Pharmacists Association, after meeting with the privacy commissioner, have agreed to scrap even the voluntary guidelines agreed upon by medical professionals. They have pledged to create “made-in-Ontario” guidelines that have as their first priority compliance with Ontario’s health privacy legislation.
Media release from Ontario Privacy Commission:
https://www.ipc.on.ca/scripts/index_.asp?action=31&P_ID=16639&N_ID=1&PT_ID=13169&U_ID=0
For information on the effects to women’s health of MAP:
https://www.morningafterpill.org/mapcpfl.htm
Contact the Ontario College of Pharmacists:
483 Huron St.,
Toronto, ON
M5R 2R4
(416) 962-4861 or
1-800-220-1921
Contact the Ontario Information and Privacy Commission:
Bob Spence
Communications Co-ordinator
Direct line: 416-326-3939
Cell phone: 416-873-9746
Toll free number: 1-800-387-0073
[email protected]